---
schema_version: "secwatch.filing_event.v1"
accession: "0001628280-24-004785"
form_type: "8-K"
ticker: "PRME"
cik: "0001894562"
company_name: "Prime Medicine, Inc."
filed_at: "2024-02-14T23:59:59+00:00"
generated_at: "2026-06-06T02:42:11.772415+00:00"
event_type: "other_material"
sentiment: "neutral"
materiality_score: 0.6
calibrated_materiality_score: 0.6
confidence: "high"
source: SEC EDGAR
---

# Prime Medicine reports preliminary cash of ~$135.2M as of Dec 31, 2023

## Summary
- Preliminary unaudited cash, equivalents, short-term investments, and restricted cash total ~$135.2M.
- Excluding $13.5M restricted cash, liquid assets are ~$121.7M.
- Company has not yet completed year-end close; final results may differ materially.
- Estimates are management-prepared and not audited; no assurance of final figures.

## SEC filing metadata
- accession: 0001628280-24-004785
- form_type: 8-K
- ticker: PRME
- cik: 0001894562
- company_name: Prime Medicine, Inc.
- filed_at: 2024-02-14T23:59:59+00:00
- event_type: other_material
- sentiment: neutral
- materiality_score: 0.6
- calibrated_materiality_score: 0.6
- confidence: high
- sec_items: 2.02
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1894562/000162828024004785/0001628280-24-004785-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1894562/000162828024004785/prme-20240214.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001628280-24-004785
- JSON: https://secwatch.observer/filing/0001628280-24-004785.json
- Plain text: https://secwatch.observer/filing/0001628280-24-004785.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.